Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder

Clinical trial NCT02871427 · TERMINATED

Trial details

NCT number: NCT02871427
Sponsor: Axovant Sciences Ltd.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Lewy Body Dementia Dementia With Lewy Bodies Parkinson's Disease Dementia Visual Hallucinations REM Sleep Behavior Disorder

Start date: 2016-10-20
Primary completion: 2019-01-17
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.